AKT1 and Parkinson disease: Notably, while α4β2 and α7 nAChRs are implicated in dopamine neuron survival via PI3K/Akt and NF-κB pathways, their exact molecular interplay in PD remains speculative due to a paucity of clinical biomarker studies.